Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anbiotec is an Italian biotechnology and medical device company specializing in the development and manufacture of advanced biomaterials for regenerative medicine and surgery. Founded in 1994 and headquartered in Rome, the company focuses on providing innovative solutions for bone and tissue regeneration, including bone substitutes, membranes, and skin substitutes. Their product portfolio, marketed under the Anbio brand, serves various clinical fields such as orthopedics, neurosurgery, and dentistry. Anbiotec integrates research and development with specialized manufacturing to produce high-quality biological grafts and synthetic substitutes. The company also offers diagnostic kits and surgical instrumentation to support comprehensive healthcare delivery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anbiotec.